1. Fda-Regulated Products and What Registration Each Requires
FDA regulates eight distinct product categories, each with its own registration mechanism and enforcement consequence for non-compliance. Misclassification is one of the most costly mistakes when entering the U.S. .arket.
What Fda Registration Does Each Product Category Require?
FDA regulates food, drugs, medical devices, cosmetics, dietary supplements, and biologics through separate frameworks with distinct registration and pre-market requirements, and a company must determine the correct category before identifying its obligations. A substance marketed as a food ingredient may be regulated as a drug if the label makes therapeutic claims, requiring a full NDA rather than simple food facility registration.
| Product Category | Registration / Submission | Key Requirement |
|---|---|---|
| Prescription drugs | NDA; facility registration | FDA approval before commercial distribution |
| Generic drugs | ANDA | Bioequivalence; patent certification |
| Medical devices — Class II | 510k premarket notification | Substantial equivalence to a predicate device |
| Medical devices — Class III | PMA (clinical data required) | Highest-risk; no predicate device available |
| Biologics | BLA (Biologics License Application) | Separate from NDA; covers manufacturing controls |
| Food facilities | Biennial registration; FSMA compliance | Foreign and domestic facilities supplying U.S. .arket |
| Cosmetics (post-MoCRA) | Facility registration + product listing | Annual renewal; ingredient disclosure |
| Dietary supplements | Facility registration; NDI notification | Notification required for novel ingredients |
Healthcare and life sciences and pharmaceutical regulatory compliance counsel can advise on registration requirements for the specific product category, assess whether classification is correct, and develop the FDA registration strategy.
How Do Food Facility Registration and the Mocra Cosmetic Registration Work?
Under FSMA, domestic and foreign food facilities must register with FDA and renew in even-numbered years, and a foreign facility whose registration is suspended cannot export to the United States. MoCRA, enacted in 2022, added facility registration and product listing requirements for cosmetic manufacturers with no equivalent under prior law, requiring registration and product listings identifying the responsible person and ingredients.
Healthcare compliance and regulatory and federal regulatory changes counsel can advise on facility registration requirements for food and cosmetic manufacturers, assess current compliance, and develop the registration and renewal strategy.
2. Medical Device Registration: Navigating 510k and Pma
Medical devices are classified by patient risk, and the required pre-market pathway depends on classification and whether a predicate device cleared by FDA exists for comparison.
What Is the Difference between a 510k and a Pma for Medical Devices?
A Class II medical device clears FDA review through a 510k premarket notification demonstrating substantial equivalence to a predicate device, focusing on safety and performance without requiring full clinical trials. A Class III device with no predicate must go through premarket approval with a full application including clinical data demonstrating reasonable assurance of safety and effectiveness before FDA permits distribution.
FDA drug approval process and healthcare and life sciences counsel can advise on the 510k vs PMA pathways, assess which the specific device requires, and develop the pre-market submission strategy.
What Does the 510k Submission Process Involve?
A 510k submission must identify a suitable predicate, describe the new device's characteristics and intended use, and provide a performance comparison showing the new device is at least as safe and effective, with FDA typically taking three to six months to review. Devices raising novel safety questions may require special 510k review with clinical data, or de novo classification for novel low-to-moderate risk devices lacking a predicate.
Pharmaceutical regulatory compliance and healthcare compliance and regulatory counsel can advise on 510k submission requirements, assess substantial equivalence eligibility, and develop the submission and FDA review strategy.
3. Drug and Biologic Approval: Nda, Anda, and the Ind Process
Prescription drugs, generic drugs, and biologics each require pre-market approval, and the specific pathway depends on whether the product is a new drug, a generic, or a biological product.
What Are the Drug Approval Pathways and How Do They Differ?
A new prescription drug requires an NDA with Phase I, II, and III clinical data plus a comprehensive manufacturing and pharmacology dossier, and a biologic requires a Biologics License Application with additional manufacturing controls. A developer seeking to begin human clinical trials must first file an Investigational New Drug application to obtain FDA authorization.
FDA drug approval process and pharmaceutical R&D compliance counsel can advise on the NDA, ANDA, and BLA pathways, assess which the specific product requires, and develop the pre-market approval strategy.
What Is the Anda Process for Generic Drug Approval?
A generic drug identical to an approved reference drug can enter the market through an ANDA, which requires proof of bioequivalence, a manufacturing site inspection, and a patent certification addressing unexpired patents. A Paragraph IV certification asserting the reference drug's patents are invalid or not infringed triggers a thirty-month stay of FDA approval and typically results in patent litigation.
Pharmaceutical regulatory compliance and life sciences licensing counsel can advise on the ANDA process for generic drug approval, assess bioequivalence and patent certification requirements, and develop the submission strategy.
4. Post-Registration Compliance and Fda Requirements for Importers
FDA registration or approval is the beginning of a regulatory relationship, not the end. Post-registration obligations include adverse event reporting, manufacturing quality compliance, and for importers, specific prior notice requirements.
What Post-Registration Compliance Obligations Does Fda Impose?
After approval, manufacturers must comply with Good Manufacturing Practice regulations, mandatory adverse event reporting when a product causes serious injury, labeling requirements, and any post-approval studies imposed as conditions of approval. A company that lapses on renewal obligations or fails to report adverse events faces warning letters, import alerts, consent decrees, and in serious cases criminal prosecution.
Healthcare compliance and regulatory and corporate compliance and risk management counsel can advise on post-registration compliance obligations, assess whether the current program satisfies FDA requirements, and develop the compliance and adverse event reporting strategy.
What Fda Registration Requirements Apply to Importers of Fda-Regulated Products?
Foreign manufacturers must register their facilities, and importers bringing FDA-regulated products through U.S. Customs must submit prior notice before each shipment and ensure products comply with all applicable FDA requirements. FDA can place a foreign manufacturer on an import alert when products are found to be violative, allowing automatic detention of all shipments until the manufacturer demonstrates compliance.
Import and trade compliance and customs compliance and enforcement counsel can advise on FDA registration requirements for importers, assess whether facilities are registered, and develop the import compliance and prior notice strategy.
27 Mar, 2026
